Powderject Moves Into Marketing Phase Via Medeva Vaccines Acquisition
Executive Summary
Powderject's acquisition of Medeva's vaccines business moves the company from the research phase into the marketing of six products, one of which is sold in the U.S.
You may also be interested in...
Rite Aid, Longs Suspend Flu Vaccines; NIAID Half-Dose Results Positive
Rite Aid and Longs Drugs have delayed plans for influenza vaccine clinics, citing continuing short supplies of the vaccine.
Rite Aid, Longs Suspend Flu Vaccines; NIAID Half-Dose Results Positive
Rite Aid and Longs Drugs have delayed plans for influenza vaccine clinics, citing continuing short supplies of the vaccine.
Baxter Adds Vaccine Production Capacity Via Peptide Therapeutics Deal
Baxter is enhancing its vaccine production capacity via a $40 mil. equity investment in Peptide Therapeutics.